OACCU · Oaktree Acquisition Corp. III Life Sciences · Executive Compensation
$10.75
At close · Nov 13
Return incl. dividend (before tax)
Going-concern doubt
— flagged Nov 13, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Such potential liquidity shortfalls and mandatory liquidation condition raise substantial doubt about the Company’s ability to continue as a going concern.”View the 10-Q filed Nov 13, 2026
Market Cap
$142.06M
Shares
13.25M
Volume · Nov 13
2500
Avg daily vol (5 sessions)
1102
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
No Compensation Data
No Summary Compensation Table has been imported from this company's proxy statements yet.
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| George A. Martinez | Chief Financial Officer (principal accounting and principal financial officer) | Appointed | 2025-10-29 |
|
Thomas Sweeney
“Mr. Sweeney’s resignation was not the result of any disagreements with the Board or management of the Company and he is resigning to pursue other professional opportunities.”
|
Chief Financial Officer | Resigned | 2025-10-29 |
| David A. Berry, MD, PhD | independent director | Appointed | 2025-10-17 |
| Thomas Sweeney | Chief Financial Officer (principal accounting and principal financial officer) | Appointed | 2025-06-06 |
|
Courtney Conigliaro
“Ms. Conigliaro’s resignation was not the result of any disagreements with the Board or management of the Company and she is resigning to pursue other professional opportunities.”
|
Chief Financial Officer | Resigned | 2025-06-06 |
| Zaid Pardesi | director of the Company | Appointed | 2025-01-07 |
| Aman Kumar | chairman of the Board | Appointed | 2025-01-07 |
|
John Frank
“Mr. Frank's resignation was not the result of any disagreement with the Company on any matter relating to the Company's operations, policies or practices.”
|
board of directors | Resigned | 2025-01-07 |
Leadership
- Aman Kumar Chairman
- George A. Martinez CFO
- Thomas Sweeney CFO
- David A. Berry Board Member
- David A. Berry, MD, PhD Board Member
- Zaid Pardesi Board Member